4K1L
4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 beta-HSD1 inhibitors for the treatment of diabetes
Summary for 4K1L
Entry DOI | 10.2210/pdb4k1l/pdb |
Descriptor | Corticosteroid 11-beta-dehydrogenase isozyme 1, (4aS,8aR)-N-cyclohexyl-4a,5,6,7,8,8a-hexahydro-4,1,2-benzoxathiazin-3-amine 1,1-dioxide, NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... (4 entities in total) |
Functional Keywords | 11-beta-hydroxysteroid dehydrogenase 1, 11-dh, 11-beta-hsd1, short chain dehydrogenase, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Endoplasmic reticulum membrane; Single-pass type II membrane protein: P28845 |
Total number of polymer chains | 4 |
Total formula weight | 131474.74 |
Authors | Loenze, P.,Schimanski-Breves, S.,Von der Heyden, C.,Engel, C.K. (deposition date: 2013-04-05, release date: 2014-04-09, Last modification date: 2023-09-20) |
Primary citation | Bohme, T.,Engel, C.K.,Farjot, G.,Gussregen, S.,Haack, T.,Tschank, G.,Ritter, K. 1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11-HSD1 inhibitors for the treatment of diabetes. Bioorg.Med.Chem.Lett., 23:4685-4691, 2013 Cited by PubMed: 23845218DOI: 10.1016/j.bmcl.2013.05.102 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.96 Å) |
Structure validation
Download full validation report